Not applicableStudy completedNCT02332642
What this trial is testing
Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy
Who this might be right for
Immuno-monitoring
Universitätsmedizin Mannheim 12
Showing 8 of 8 results